Traumatic Brain Injury Assessment & Management Devices Market

Traumatic Brain Injury Assessment & Management Devices Market Size Worth US$ 10.5 Bn by 2030

SHARE THIS ARTICLE

The global traumatic brain injury assessment & management devices market size is expected to be worth around US$ 10.5 billion by 2030, according to a new report by Vision Research Reports.

The global traumatic brain injury assessment & management devices market size was valued at US$ 3.9 billion in 2020 and is anticipated to grow at a CAGR of 9.3% during forecast period 2021 to 2030.

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38819

Traumatic Brain Injury Assessment & Management Devices Market (By Device: Imaging Devices, Monitoring Devices; By Technique: Intracranial Pressure (ICP) Monitoring, Partial Pressure of Oxygen in Brain Tissue (pBrO2); By End-use: Hospitals, Diagnostic Centers, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Report Coverage

Report Scope Details
Market Size US$ 10.5 Bn by 2030
Growth Rate CAGR of 9.3% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Device, technique, end-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned BioDirection, Inc.; BrainScope Company, Inc.; Neural Analytics, Inc.; Compumedics Ltd.; Integra LifeSciences; Natus Medical, Inc.

Growth Factors

 The increasing prevalence of traumatic brain injuries (TBIs), rising patients’ preference for minimally invasive procedures, and rising awareness regarding brain injuries are the major factors expected to fuel the market growth. In addition, the adoption of technologically advanced products and supportive government policies are few more factors contributing to the market growth. Traumatic brain injuries are permanent or temporary impairment to the brain that can be caused by a blow, bump, or shock to the skull. Major causes of TBIs include sports injuries, falls, gunshot wounds, domestic violence, and road traffic accidents.

By Device Analysis

The imaging devices segment dominated the market with a share of 55.04% in 2020. The imaging devices are further segmented into computed tomography (CT), magnetic resonance imaging (MRI) devices, X-ray, and others.

The monitoring devices segment is expected to expand at the highest CAGR of 9.6% from 2021 to 2030 owing to the minimally invasive nature of these devices, increasing awareness, and improvement in healthcare facilities.

By Technique Analysis

The intracranial pressure (ICP) monitoring segment dominated the market with a share of 55.61% in 2020. This method is considered to be a gold standard for the accurate measurement of intracranial pressure in patients with severe brain injury.

The partial pressure of oxygen in the brain tissue (pBrO2) segment is expected to expand at the highest CAGR of 8.10% from 2021 to 2030. Continuous pBrO2 monitoring provides timely information about cerebral oxygen demand in patients suffering from traumatic brain injury.

By End-use Analysis

The hospitals’ segment dominated the market with a share of 43.17% in 2020 owing to the increase in the number of brain surgeries performed in hospitals as well as a surge in the prevalence of TBIs patients globally.

The others’ segment including ambulatory surgical centers, research centers, and emergency clinics is expected to expand at the highest CAGR of 8.10% from 2021 to 2030. This is attributed to numerous advantages offered by emergency clinics and ASCs such as shorter procedure time and same-day discharge as compared to hospitals.

By Regional Analysis

 North America dominated the market with a share of 53.73% in 2020. This is attributed to the presence of well-established healthcare facilities in the region, increasing government initiatives, awareness campaigns regarding brain injuries, and greater incidence of traumatic brain injuries in the region.

The Asia Pacific region is expected to expand at the highest CAGR of 10.9% from 2021 to 2030. This is attributed to factors such as growth in the aging population, rise in the number of people suffering from traumatic brain injuries, increasing incidence of road accidents, and violence.

Key Players

  • BrainScope Company, Inc.
  • Neural Analytics, Inc.
  • Advanced Brain Monitoring Inc.
  • Natus Medical, Inc.
  • Integra Lifesciences
  • BioDirection, Inc.
  • Nihon Kohden Corporation
  • Compumedics Ltd.
  • InfraScan, Inc.
  • Oculogica
  • Raumedic AG

Market Segmentation

  • By Device
    • Imaging Devices
      • Magnetic Resonance Imaging (MRI) Devices
      • X-ray
      • Computed Tomography
      • Others
    • Monitoring Devices
  • By Technique
    • Intracranial Pressure (ICP) Monitoring
    • Partial Pressure of Oxygen in Brain Tissue (pBrO2)
  • By End-use
    • Hospitals
    • Diagnostic Centers
    • Others
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
    • Middle East and Africa (MEA)
      • South Africa
      • Saudi Arabia
      • UAE

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Traumatic Brain Injury Assessment & Management Devices Market, By Device

7.1.  Traumatic Brain Injury Assessment & Management Devices Market, by Device, 2021-2030

7.1.1.    Imaging Devices

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Monitoring Devices

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Traumatic Brain Injury Assessment & Management Devices Market, By Technique

8.1.  Traumatic Brain Injury Assessment & Management Devices Market, by Technique, 2021-2030

8.1.1.    Intracranial Pressure (ICP) Monitoring

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Partial Pressure of Oxygen in Brain Tissue (pBrO2)

8.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Traumatic Brain Injury Assessment & Management Devices Market, By End User

9.1.  Traumatic Brain Injury Assessment & Management Devices Market, by End User, 2021-2030

9.1.1.    Hospitals

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Diagnostic Centers

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Others

9.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Traumatic Brain Injury Assessment & Management Devices Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Device (2017-2030)

10.1.2.  Market Revenue and Forecast, by Technique (2017-2030)

10.1.3.  Market Revenue and Forecast, by End User (2017-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Device (2017-2030)

10.1.4.2.      Market Revenue and Forecast, by Technique (2017-2030)

10.1.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Device (2017-2030)

10.1.5.2.      Market Revenue and Forecast, by Technique (2017-2030)

10.1.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Device (2017-2030)

10.2.2.  Market Revenue and Forecast, by Technique (2017-2030)

10.2.3.  Market Revenue and Forecast, by End User (2017-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Device (2017-2030)

10.2.4.2.      Market Revenue and Forecast, by Technique (2017-2030)

10.2.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Device (2017-2030)

10.2.5.2.      Market Revenue and Forecast, by Technique (2017-2030)

10.2.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Device (2017-2030)

10.2.6.2.      Market Revenue and Forecast, by Technique (2017-2030)

10.2.6.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Device (2017-2030)

10.2.7.2.      Market Revenue and Forecast, by Technique (2017-2030)

10.2.7.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Device (2017-2030)

10.3.2.  Market Revenue and Forecast, by Technique (2017-2030)

10.3.3.  Market Revenue and Forecast, by End User (2017-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Device (2017-2030)

10.3.4.2.      Market Revenue and Forecast, by Technique (2017-2030)

10.3.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Device (2017-2030)

10.3.5.2.      Market Revenue and Forecast, by Technique (2017-2030)

10.3.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Device (2017-2030)

10.3.6.2.      Market Revenue and Forecast, by Technique (2017-2030)

10.3.6.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Device (2017-2030)

10.3.7.2.      Market Revenue and Forecast, by Technique (2017-2030)

10.3.7.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Device (2017-2030)

10.4.2.  Market Revenue and Forecast, by Technique (2017-2030)

10.4.3.  Market Revenue and Forecast, by End User (2017-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Device (2017-2030)

10.4.4.2.      Market Revenue and Forecast, by Technique (2017-2030)

10.4.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Device (2017-2030)

10.4.5.2.      Market Revenue and Forecast, by Technique (2017-2030)

10.4.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Device (2017-2030)

10.4.6.2.      Market Revenue and Forecast, by Technique (2017-2030)

10.4.6.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Device (2017-2030)

10.4.7.2.      Market Revenue and Forecast, by Technique (2017-2030)

10.4.7.3.      Market Revenue and Forecast, by End User (2017-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Device (2017-2030)

10.5.2.  Market Revenue and Forecast, by Technique (2017-2030)

10.5.3.  Market Revenue and Forecast, by End User (2017-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Device (2017-2030)

10.5.4.2.      Market Revenue and Forecast, by Technique (2017-2030)

10.5.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Device (2017-2030)

10.5.5.2.      Market Revenue and Forecast, by Technique (2017-2030)

10.5.5.3.      Market Revenue and Forecast, by End User (2017-2030)

Chapter 11.  Company Profiles

11.1.              BrainScope Company, Inc.

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Neural Analytics, Inc.

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Advanced Brain Monitoring Inc.

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Natus Medical, Inc.

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Integra Lifesciences

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              BioDirection, Inc.

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Nihon Kohden Corporation

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Compumedics Ltd.

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              InfraScan, Inc.

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Oculogica

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Buy This Premium Research Report, click here@https://www.visionresearchreports.com/report/cart/38819 or call: +1 9197 992 333

Daksh

Daksh is an SEO Analyst having 3 years of experienced. we can quickly understand and support initiatives that will contribute to the goals and success of client campaigns. and also Perform keyword research in coordination with client business objectives to optimize existing content and uncover new opportunities.

View all posts by Daksh →

Leave a Reply

Your email address will not be published. Required fields are marked *